The AIDS response faces both an economic recession and optimism about ending AIDS. The financing needs of the HIV response will remain substantial for many years, with current commitments becoming increasingly out of line with future fiscal liabilities.
RethinkHIV researchers Anna Vassall, Michelle Remme, Charlotte Watts, Timothy Hallett, Mariana Siapka, and Rifat Atun, author this paper with Peter Vickerman, Fern Terris-Prestholt, Markus Haacker, Lori Heise, Andy Haines, and Peter Piot.
They find that a change in economic approach will be required, drawing on increased domestic funding, improvements in efficiency, and identification of innovative new funding streams.
Organisations providing HIV services must critically examine and justify their costs and priorities, become increasingly involved in broader health systems strengthening, and find ways to simultaneously support good governance and wider development objectives.
They also argue that there is a need for a renewed economic case to be made for a reinvigorated response and a sustainable, long-term national and global financial commitment to ending AIDS.
Citation: Vassall, A.; Remme, M.; Watts, C.; Hallett, T.; Siapka, M.; Vickerman, P.; Terris-Prestholt, F.; Haacker, M.; Heise, L.; Haines, A.; Atun, R.; Piot, P. Financing Essential HIV Services: A New Economic Agenda. PLoS Medicine (2013) 10 (12) e1001567. [DOI: 10.1371/journal.pmed.1001567]
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.